###begin article-title 0
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr Triggers Natural Killer Cell-Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response
###end article-title 0
###begin p 1
Conceived and designed the experiments: J. Ward, J. DeHart, E. Zimmerman, D. Mavilio, V. Planelles, E. Barker. Performed the experiments: J. Ward, Z. Davis, A. Bosque, E. Barker. Analyzed the data: J. Ward, Z. Davis, V. Planelles, E. Barker. Contributed reagents/materials/analysis tools: J. DeHart, E. Brunetta, D. Mavilio. Wrote the paper: J. Ward, Z. Davis, V. Planelles, E. Barker.
###end p 1
###begin p 2
###xml 351 354 351 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 954 957 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 1229 1235 1229 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCAF-1</sup>
###xml 1421 1424 1421 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 132 160 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 169 174 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 504 509 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 656 661 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1010 1015 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1435 1440 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1501 1506 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Natural killer (NK) cells are stimulated by ligands on virus-infected cells. We have recently demonstrated that NK cells respond to human immunodeficiency virus type-1 (HIV-1)-infected autologous T-cells, in part, through the recognition of ligands for the NK cell activating receptor NKG2D on the surface of the infected cells. Uninfected primary CD4pos T-cell blasts express little, if any, NKG2D ligands. In the present study we determined the mechanism through which ligands for NKG2D are induced on HIV-1-infected cells. Our studies reveal that expression of vpr is necessary and sufficient to elicit the expression of NKG2D ligands in the context of HIV-1 infection. Vpr specifically induces surface expression of the unique-long 16 binding proteins (ULBP)-1 and ULBP-2, but not ULBP-3, MHC class I-related chain molecules (MIC)-A or MIC-B. In these studies we also demonstrated that Vpr increases the level of ULBP-1 and ULBP-2 mRNA in primary CD4pos T-cell blasts. The presence of ULBP-1 and ULBP-2 on HIV-1 infected cells is dependent on the ability of Vpr to associate with a protein complex know as Cullin 4a (Cul4a)/damaged DNA binding protein 1 (DDB1) and Cul4a-associated factor-1(DCAF-1) E3 ubiquitin ligase (Cul4aDCAF-1). ULBP-1 and -2 expression by Vpr is also dependent on activation of the DNA damage sensor, ataxia telangiectasia and rad-3-related kinase (ATR). When T-cell blasts are infected with a vpr-deficient HIV-1, NK cells are impaired in killing the infected cells. Thus, HIV-1 Vpr actively triggers the expression of the ligands to the NK cell activation receptor.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 267 272 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 411 416 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 485 488 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 901 904 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 927 932 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Natural killer (NK) cells are part of the innate immune response against virus infection and cancer. Recently we demonstrated that ligands for the NK cell activation receptor, NKG2D, trigger NK cell-mediated response to infected cells. These ligands are expressed on HIV-1-infected cells and not on uninfected cells. Despite the observation that NKG2D ligands are expressed on infected cells, it is unclear how HIV-1 induces their expression. In the present study, we demonstrate that HIV induces the ligands of the NKG2D receptor through the viral gene product Vpr. Vpr triggers a DNA damage response in infected cells, which in turn, increases virus production. We also demonstrate that by blocking the activity of ATR, a major component in the DNA damage response, we were able to prevent NKG2D ligand expression. When Vpr was removed from the virus genome, NK cells lost their ability to lyse the HIV-infected cells. Thus, HIV-1 actively triggers NK cells through the activity of its viral gene product, Vpr.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bukowski1">[1]</xref>
###xml 313 316 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Habu1">[2]</xref>
###xml 317 320 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-SteinStreilein1">[3]</xref>
###xml 510 513 510 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Lopez1">[4]</xref>
###xml 514 517 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Jawahar1">[5]</xref>
###xml 535 538 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Quinnan1">[6]</xref>
###xml 561 564 561 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Echevarria1">[7]</xref>
###xml 686 689 686 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Biron1">[8]</xref>
###xml 690 693 690 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Dalloul1">[9]</xref>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Etzioni1">[10]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Joncas1">[11]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Aoukaty1">[12]</xref>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Orange1">[13]</xref>
###xml 263 269 <span type="species:ncbi:10090">murine</span>
###xml 414 420 <span type="species:ncbi:9606">humans</span>
###xml 543 560 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 586 592 <span type="species:ncbi:9606">humans</span>
NK cells are involved in the immune response against tumor cells and virus-infected cells without the requirement for previous exposure to their targets or their products. The importance of NK cells in restraining viral infection was first shown in studies using murine models in which NK cells were depleted [1],[2],[3]. In these studies, NK cell depletion led to enhanced viral replication and cytopathology. In humans, NK cells control the severity of viral infections such as those by herpes simplex virus [4],[5], cytomegalovirus [6] and hepatitis B virus [7]. Lack of NK cells in humans or defects in NK cell function are associated with fatal disseminated herpes virus infection [8],[9],[10],[11],[12],[13].
###end p 6
###begin p 7
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bratke1">[14]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fellows1">[15]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Keefe1">[16]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Criado1">[17]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Keefe1">[16]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Arase1">[18]</xref>
###xml 686 693 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dim</sup>
###xml 783 786 783 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Cooper1">[19]</xref>
###xml 865 871 865 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bright</sup>
###xml 876 879 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 1000 1006 1000 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bright</sup>
###xml 1047 1050 1047 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dim</sup>
One of the major roles of NK cells in controlling viruses is the destruction of the infected cells. Direct target cell killing by NK cells is mediated by the regulated release of granules containing perforin and granzymes [14],[15]. Perforin forms pores in the plasma membrane allowing ions and small particles into and out of the cell [16]. The granzymes most likely enter the target cell through perforin-formed channels [17] or endocytosis [16] and induce apoptosis of the infected cells. NK cells may also kill through engagement of death receptors (e.g., Fas) by ligands expressed on the NK cell surface (e.g., CD178) whose surface expression is increased upon degranulation [18]. In vivo, cytotoxic function is primarily mediated by the subset of NK cells that are CD56dim/CD16pos, the dominant subset in the peripheral blood of healthy individuals [19]. CD56bright/CD16neg cells constitute a minor NK population in the blood but are the major NK cell subset in secondary lymphoid tissues. CD56bright NK cells express less perforin than CD56dim NK cells but higher concentrations of cytokines and as such are important in regulating immune responses.
###end p 7
###begin p 8
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Lanier1">[20]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Lanier1">[20]</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Moretta1">[21]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Houchins1">[22]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Wu1">[23]</xref>
###xml 1428 1432 1428 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Lanier1">[20]</xref>
NK cell release of cytotoxic contents is regulated by a large array of signals provided by a variety of membrane-bound, activating receptors expressed on NK cells that interact with their corresponding ligands on target cells (see [20] for a current list of all known activating receptors and their ligands). Almost all NK cell activating receptors interact with adaptor proteins containing activation domains [20]. Activation receptors can be divided into those associated with intracellular tyrosine activation motifs (ITAM)-containing adaptor molecules and those associating with adaptor molecules lacking ITAMs. ITAM-dependent receptors include: CD16 (low affinity IgG receptor), and the natural cytotoxicity receptors (NCRs; NKp30, NKp44 and NKp46) [21]. The NKG2D receptor is an example of an ITAM-independent activation receptor. NKG2D is found on almost all peripheral blood NK cells and is a member of the NKG2 receptor family. NKG2D does not associate with CD94, but forms homo-dimers on the membrane of NK cells [22],[23]. Although NKG2D specifically recognizes its ligands on target cells and is important for activation of NK cells, it does not induce signal transduction within the cells. For this purpose, NKG2D associates, on the membrane, with the DAP10 adaptor molecule. The DAP10 adaptor protein contains a YXXM motif instead of ITAM and recruits phosphatidylinositol-3- kinase and Grb-2 upon phosphorylation [20].
###end p 8
###begin p 9
###xml 18 22 18 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ward1">[24]</xref>
###xml 23 27 23 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Cerboni1">[26]</xref>
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bauer1">[27]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Cosman1">[28]</xref>
###xml 365 373 365 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 525 532 525 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 588 591 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ward1">[24]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 287 290 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 468 476 <span type="species:ncbi:9606">patients</span>
###xml 614 619 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 721 726 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our prior studies [24],[25] and those of others [26] indicate that HIV-1-infection of primary CD4pos T-cells leads to the surface expression of NKG2D ligands. The ligands for human NKG2D are the MIC-A and -B and ULBP 1-4 [27],[28]. ULBPs but not MIC-A or -B were found on the surface of HIV-infected cells in our prior studies. We not only found these molecules on in vitro infected primary CD4pos T-cell blasts but also on infected cells obtained from HIV-1-infected patients after amplification of the virus-infected cells ex vivo[25]. In addition, these studies, which used primary CD4pos T-cells infected with HIV-1 as targets for autologous NK cells in cytotoxicity assays, revealed that NK cells can respond to the HIV-1-infected cells in an NKG2D-dependent manner [24],[25].
###end p 9
###begin p 10
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Gasser1">[29]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Gasser1">[29]</xref>
###xml 368 369 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Roshal1">[30]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zimmerman1">[31]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Goh1">[32]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zhu1">[33]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Forget1">[34]</xref>
###xml 586 587 586 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Roshal1">[30]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zimmerman2">[35]</xref>
###xml 275 280 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 448 453 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 677 682 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A recent study by Gasser et al. demonstrated, that DNA damage induced expression of a plethora of NKG2D ligands [29]. The up-regulation of NKG2D ligands occurred after the activation of the DNA damage recognition enzymes ataxia telangiectasia mutated (ATM) and ATR [29]. The HIV-1 Vpr protein is a potent activator of ATR, and induces infected cells to arrest in the G2 phase of the cell cycle, [30],[31] and increases viral transcription from the HIV-1 long-terminal repeat [32],[33],[34]. Our previous studies have demonstrated that the ability of Vpr to induce cell cycle arrest in G2 is dependent on activation of ATR but not ATM [30],[35]. Therefore, we hypothesized that HIV-1 Vpr is responsible for inducing the expression of NKG2D ligands during infection through activation of ATR. We further hypothesized that Vpr-mediated up-regulation of NKG2D ligands would lead to NK cell activation. If these hypotheses are correct, this would indicate that the DNA damage signaling by Vpr has consequences that may potentially be detrimental to the virus because they enhance immune surveillance by NK cells.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Vpr induces expression of the NKG2D ligands, ULBP-1 and ULBP-2
###end title 12
###begin p 13
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Goh1">[32]</xref>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zhu1">[33]</xref>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 333 341 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Andersen1">[36]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bosque1">[37]</xref>
###xml 738 747 738 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s001">Figure S1</xref>
###xml 233 238 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 385 391 <span type="species:ncbi:9606">humans</span>
Initially, we determined the role of Vpr in the up-regulation of NKG2D ligands on primary CD4pos T-cells. To eliminate possible differences in replication kinetics due to the presence or absence of Vpr [32],[33], we used a defective HIV-1 construct, DHIV, that has a deletion in the env gene. We then provided the VSV-G glycoprotein in trans, to form pseudotyped virions [36],[37]. In humans, six different NKG2D ligands have been reported to date. In order to be able to detect global changes in the expression of all six NKG2D ligands, we utilized a recombinant soluble NKG2D receptor that binds to all of them. We stained the cells with viability dyes and evaluated only the viable infected population for expression of NKG2D ligands (Figure S1).
###end p 13
###begin p 14
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 170 179 170 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g001">Figure 1A</xref>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 759 762 759 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 785 788 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 839 848 839 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g001">Figures 1</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s002">S2</xref>
###xml 1054 1059 1054 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4/3</sub>
###xml 1076 1085 1076 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g001">Figure 1B</xref>
###xml 1114 1120 1114 1120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4/3.</sub>
###xml 285 290 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 747 752 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1049 1052 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1109 1112 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We tested the binding of soluble NKG2D as a measure of ligand expression in PBMC from five individuals, in the presence or absence of in vitro DHIV infection. As seen in Figure 1A, CD4pos T-cells infected with DHIV wild type (WT) expressed NKG2D ligands [MFI = 687 for infected cells (HIV-1 p24 Agpos/CD4neg) compared with MFI = 159 for uninfected control]. Experiments were performed in parallel for a total of 5 donors and the statistical difference in MFI between the infected and uninfected groups in five individuals was p<0.01 based on the Student's t-test. Uninfected cells did not detectably express NKG2D ligands (MFI = 152 for uninfected cells compared with MFI = 159 for secondary Ab staining). Within the infected population, only the HIV-1 p24 Agpos cells, but not the p24neg in the same culture, expressed NKG2D ligands (see Figures 1 and S2). Therefore, we conclude that NKG2D is not induced on uninfected, bystander cells. DHIV does not encode the envelope glycoprotein; however NKG2D ligands are also induced on envelope-expressing HIV-1NL4/3-infected cells (Figure 1B). DHIV is derived from HIV-1NL4/3. Thus, DHIV-infected cells express NKG2D ligands on their cell surface.
###end p 14
###begin title 15
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
Infected primary CD4pos T-cells express NKG2D ligands.
###end title 15
###begin p 16
###xml 18 23 18 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4/3</sub>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 485 488 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 511 514 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 251 255 <span type="species:ncbi:9925">goat</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
###xml 316 321 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 499 504 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DHIV (A) and HIV-1NL4/3 (B) -infected primary T-cell blasts and uninfected CD4pos T-cells were surface stained with fluorochrome-conjugated anti-CD4 Ab and a fusion protein of human NKG2D and the Fc portion of human IgG1 along fluorochrome-conjugated goat anti-human IgG1. All cells were stained intracellularly for HIV-1 p24 antigen (Ag). Histograms were derived following acquisition on a flow cytometer of either 104 viable cells [(for uninfected cells) blue line] or 104 viable CD4neg cells and HIV-1 p24 Agpos infected cells (red line). As controls (green line), cells were stained with secondary Ab alone. This figure is representative of five separate experiments.
###end p 16
###begin p 17
###xml 227 236 227 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g002">Figures 2</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s002">S2</xref>
###xml 335 344 331 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g002">Figure 2B</xref>
###xml 372 375 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 379 382 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 428 431 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 435 438 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 628 631 620 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 669 678 657 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g002">Figure 2C</xref>
###xml 706 709 694 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 713 716 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 762 765 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 769 772 757 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 805 814 789 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g002">Figure 2D</xref>
###xml 842 845 826 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 849 852 833 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 898 901 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 905 908 889 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 945 954 925 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g002">Figure 2E</xref>
###xml 982 985 962 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 989 992 969 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 1038 1041 1018 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 1045 1048 1025 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 1193 1202 1161 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g002">Figure 2A</xref>
###xml 360 365 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 416 421 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 694 699 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 750 755 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 830 835 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 886 891 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 970 975 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1026 1031 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1248 1253 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We then sought to determine whether Vpr was responsible for the expression of NKG2D ligands. We generated DHIV containing a truncation in Vpr. As controls, mutants of DHIV unable to express Vif, Vpu or Nef were also generated. Figures 2 and S2 illustrate that the DHIV-DeltaVpr infected cells failed to induce NKG2D ligand expression (Figure 2B; MFI = 188 for HIV-1 p24 Agpos/CD4neg infected cells and MFI = 216 for HIV-1 p24 Agneg/CD4pos infected cells). The MFI for DHIV-WT infected cells was statistically different (p<0.01) compared to the MFI for DHIV-DeltaVpr infected cells. We compared expression of NKG2D ligands on CD4pos T-cells infected with DHIV-DeltaVif (Figure 2C; MFI = 600 for HIV-1 p24 Agpos/CD4neg infected cells and MFI = 260 for HIV-1 p24 Agneg/CD4pos infected cells), DHIV-DeltaVpu (Figure 2D; MFI = 777 for HIV-1 p24 Agpos/CD4neg infected cells and MFI = 247 for HIV-1 p24 Agneg/CD4pos infected cells), and DHIV-DeltaNef (Figure 2E; MFI = 698 for HIV-1 p24 Agpos/CD4neg infected cells and MFI = 303 for HIV-1 p24 Agneg/CD4pos infected cells). Therefore, expression of NKG2D ligands induced by DeltaVif, DeltaVpu and DeltaNef DHIV was comparable that induced by WT DHIV (Figure 2A). Thus, we conclude that Vpr is required for HIV-1-mediated up-regulation of NKG2D ligands on the surface of infected cells.
###end p 17
###begin title 18
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
Expression of NKG2D ligands on CD4pos T-cells following infection with viruses unable to express Vpr, Vif, Vpu or Nef.
###end title 18
###begin p 19
###xml 124 127 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 459 460 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 471 474 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 521 522 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 533 536 517 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 553 556 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 302 306 <span type="species:ncbi:9925">goat</span>
###xml 312 317 <span type="species:ncbi:9606">human</span>
###xml 367 372 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 541 546 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infected primary T-cell blasts [(A) Wild-type, (B) DeltaVpr, (C) DeltaVif, (D) DeltaVpu and (E) DeltaNef] and uninfected CD4pos T-cells were surface stained with fluorochrome-conjugated anti-CD4 Ab and a fusion protein of human NKG2D and the Fc portion of human IgG1 along with fluorochrome-conjugated goat anti-human IgG1. All cells were stained intracellularly for HIV-1 p24 Ag. Histograms were derived following acquisition on a flow cytometer of either 104 viable CD4pos cells [(for uninfected cells) blue line] or 104 viable CD4neg and HIV-1 p24 Agpos infected cells (red line). The figure is representative data from three separate experiments.
###end p 19
###begin p 20
###xml 351 354 351 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 364 372 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g003">Figure 3</xref>
###xml 123 128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 408 413 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine whether Vpr expression is sufficient to induce NKG2D ligands, we resorted to a lentiviral vector that encodes HIV-1 Vpr and GFP but no other viral gene (pPR-VIP). As a control, we used a similar lentiviral vector encoding only GFP. We observed that Vpr alone, but not the control lentiviral vector, was able to induce NKG2D ligands on CD4pos T-cells (Figure 3). Therefore, Vpr is sufficient for HIV-1 to induce NKG2D ligands on the infected cell surface.
###end p 20
###begin title 21
Vpr alone is capable of inducing NKG2D ligands surface expression.
###end title 21
###begin p 22
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 465 466 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 522 523 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 534 537 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 319 324 <span type="species:ncbi:9606">human</span>
###xml 365 369 <span type="species:ncbi:9925">goat</span>
###xml 375 380 <span type="species:ncbi:9606">human</span>
Primary CD4pos T-cell blasts were transduced with a lentivirus vector (pPR-Vip) coexpressing Vpr and GFP (red line). As a control the same cells were infected with a lentivirus vector expressing GFP only (green line). Following transduction cells were stained with a fusion protein of human NKG2D and the Fc portion of human IgG1 along with fluorochrome-conjugated goat anti-human IgG1. Histograms were derived following acquisition on a flow cytometer of either 104 viable cells [(for untransduced cells) blue line] or 104 viable GFPpos cells (green and red line). The figure is representative data from two separate experiments.
###end p 22
###begin p 23
###xml 27 36 27 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g001">Figures 1</xref>
###xml 37 37 37 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g002"/>
###xml 37 38 37 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g003">3</xref>
###xml 360 368 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4</xref>
###xml 415 424 415 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4A</xref>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4C</xref>
###xml 665 674 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4E</xref>
###xml 768 777 768 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4G</xref>
###xml 873 882 873 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4I</xref>
The studies illustrated in Figures 1-3 utilized a soluble NKG2D construct that is unable to distinguish between the various ligands. Hence, we wished to determine which of the NKG2D ligands were specifically induced by Vpr. For this purpose, we compared the expression of ULBP-1, ULBP-2, ULBP-3, MIC-A and MIC-B on DHIV-infected cells. In the studies shown in Figure 4, we demonstrate that WT virus induced ULBP-1 (Figure 4A; MFI = 483 for WT virus-infected cells compared with MFI = 167 for uninfected cells) and ULBP-2 (Figure 4C; MFI = 539 for WT virus-infected cells compared with MFI = 131 for uninfected cells). In contrast, little or no induction of ULBP-3 (Figure 4E; MFI = 150 for WT virus-infected cells compared with MFI = 134 for uninfected cells), MIC-A (Figure 4G; MFI = 187 for WT virus-infected cells compared with MFI = 106 for uninfected cells) or MIC-B (Figure 4I; MFI = 99.8 for WT virus-infected cells compared with MFI = 90.5 for uninfected cells) was detected.
###end p 23
###begin title 24
Vpr is more likely to induce surface expression of ULBP-1 and ULBP-2 than ULBP-3, MIC-A or MIC-B on infected cells.
###end title 24
###begin p 25
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 228 231 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 592 593 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 615 618 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 642 643 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 654 657 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 674 677 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 118 123 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 522 527 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 662 667 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary CD4pos T-cell blasts were infected with wild-type (WT) HIV-1. As a control, the same cells were infected with HIV-1 that was deficient in expression of Vpr (DeltaVpr). As an additional control we evaluated uninfected CD4pos T-cells for expression of individual NKG2D ligands (blue lines). Following infection, cells were surface stained using fluorochrome-conjugated mAb specific for: CD4 (A-J), ULBP-1 (A-B), ULBP-2 (C-D), ULBP-3 (E-F), MIC-A (G-H) or MIC-B (I-J). The cells were then intracellularly stained for HIV-1 p24 antigen. Histograms were derived following acquisition of 104 viable uninfected CD4pos cells (blue line) or 104 viable CD4neg and HIV-1 p24 Agpos infected cells (red line). Green line represents the histogram of staining controls (isotype controls). The figure is representative data from two separate experiments.
###end p 25
###begin p 26
###xml 59 68 55 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4B</xref>
###xml 179 188 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4D</xref>
###xml 308 313 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DHIV-DeltaVpr induced considerably lower levels of ULBP-1 (Figure 4B; MFI = 220 for DeltaVpr virus-infected cells compared with MFI = 485 for WT virus-infected cells) and ULBP-2 (Figure 4D; MFI = 179 for DeltaVpr virus-infected cells compared with MFI = 539 for WT virus-infected cells) than WT virus. Thus, HIV-1 primarily induces the expression of ULBP-1 and ULBP-2 through Vpr.
###end p 26
###begin title 27
Induction of ULBP-1 and ULBP-2 by Vpr occurs at the level of gene expression
###end title 27
###begin p 28
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 320 328 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g005">Figure 5</xref>
###xml 776 784 768 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g005">Figure 5</xref>
###xml 1012 1017 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Next we asked whether induction of NKG2D ligands on infected cells was accomplished through increased steady-state levels of ULBP-1 and ULBP-2 mRNA. We infected CD4pos T-cells with DHIV and select mutants, and then measured the mRNA levels of ULBP-1, ULBP-2, ULBP-3, MIC-A and MIC-B relative to the level of GADPH mRNA (Figure 5). We found that both ULBP-1 and ULBP-2 mRNA levels were 15-fold higher in WT virus-infected cells compared with ULBP-1 and ULBP-2 gene products in uninfected cells. In comparison to WT DHIV-infected cells, DHIV-DeltaVif-infected cells showed little or no changes in ULBP-1 and ULBP-2 mRNA levels. In addition, in DHIV-DeltaVpr-infected cells, the levels of ULBP-1 and -2 mRNA were 3 to 10-fold lower compared with those in WT DHIV-infected cells (Figure 5). Infection with WT DHIV only induced a 1.5-fold increase in the expression ULBP-3, MIC-A and MIC-B. Thus, among the five NKG2D ligands we evaluated, Vpr is responsible for up-regulating the levels of ULBP-1 and ULBP-2 mRNA in HIV-1-infected cells.
###end p 28
###begin title 29
Vpr is involved in upregulating the expression of ULBP-1 and ULBP-2 mRNA.
###end title 29
###begin p 30
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 330 351 330 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 23 26 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
RNA was extracted from HIV-infected CD4pos T-cell blasts and uninfected cells and reverse transcribed. Relative copy numbers of NKG2D ligands were determined by real-time PCR using NKG2D-ligand specific primer pairs and normalized relative to GAPDH expression. The relative increase in copy numbers was calculated as described in Materials and Methods. The relative copy numbers for the indicated primer pair in uninfected cells was set to 1. Error bars indicate the standard deviations of the mean of samples in triplicate.
###end p 30
###begin title 31
###xml 81 87 81 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCAF-1</sup>
Expression of NKG2D ligands requires Vpr's ability to interact with the Cullin 4aDCAF-1 E3 ubiquitin ligase and to activate ATR
###end title 31
###begin p 32
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart1">[38]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart2">[39]</xref>
###xml 413 414 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zimmerman2">[35]</xref>
Vpr induces G2 arrest of infected cells through interaction with a Cul4a-based ubiquitin ligase that also contains the adaptor, DDB1, and the substrate receptor, DCAF1 (reviewed in [38]). Despite the fact that the degradation target for this ubiquitin ligase is unknown, the consequences of the Vpr-E3 complex are well documented. The main result is the activation of the ATR kinase [39] that, in turn, leads to G2 arrest [35]. Therefore, we wished to determine whether Vpr recruitment of the Cullin-4a-based E3 ubiquitin ligase complex is required for ULBP-1 and -2 expression.
###end p 32
###begin p 33
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart2">[39]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-LeRouzic1">[40]</xref>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart2">[39]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-LeRouzic1">[40]</xref>
###xml 623 631 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g006">Figure 6</xref>
###xml 1022 1023 1022 1023 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1059 1068 1059 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s003">Figure S3</xref>
We first tested whether domains in Vpr that are involved in recruiting or activating the Cullin-4a-based E3 ubiquitin ligase were required for induction of ULBP-1 and ULBP-2. The Vpr Q65R and Vpr R80A mutations have been previously shown to abate the ability of Vpr to induce cell cycle arrest [39],[40]. Vpr Q65R is unable to bind to DCAF1; the exact defect induced by R80A mutation is unknown, and it has been proposed that R80A abates the interaction between Vpr and the ubiquitination target for the E3/Vpr complex [39],[40]. For this purpose, we generated DHIV mutants with the above substitutions in Vpr. As shown in Figure 6, expression of NKG2D ligands was diminished by either substitution, although Vpr(R80A) had a more dramatic effect than Vpr(Q65R) (18 percent of wild-type Vpr and 48 percent of wild-type Vpr, respectively). The cell cycle profiles were examined in infected cells to visualize functional deficits in these mutants. When Vpr R80A or Vpr Q65R, were expressed neither mutant virus could induce G2 arrest as effectively as WT virus (Figure S3).
###end p 33
###begin title 34
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Regions of Vpr that are involved in the ability of Vpr to induce arrest in the cell cycle at the G2 phase are also important in NKG2D ligand expression.
###end title 34
###begin p 35
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 496 497 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 501 504 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 555 556 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 567 570 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 258 262 <span type="species:ncbi:9925">goat</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 392 397 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary T-cell blasts infected with wild type HIV-1 and HIV-1 with various mutations in Vpr were surface stained with fluorochrome-conjugated anti-CD4 Ab and a fusion protein of human NKG2D and the Fc portion of human IgG1 along with fluorochrome-conjugated goat anti-human IgG1. Uninfected CD4pos T-cells were surface stained in a similar fashion. All cells were stained intracellularly for HIV-1 p24 Ag. The mean fluorescent intensity of NKG2D ligand staining was obtained from collection of 104 CD4neg p24pos cells for all infected cells, and of the 104 CD4pos p24neg cells for the uninfected control. This figure is a representative of three separate experiments.
###end p 35
###begin p 36
###xml 181 189 181 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g007">Figure 7</xref>
###xml 192 199 192 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 209 218 209 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s004">Figure S4</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-An1">[41]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Hrecka1">[42]</xref>
###xml 561 570 561 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g007">Figure 7C</xref>
###xml 659 668 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g007">Figure 7B</xref>
###xml 693 702 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g007">Figure 7A</xref>
###xml 784 790 784 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCAF-1</sup>
###xml 251 256 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 738 743 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To more directly assess the requirement of the Cullin-4a-based E3 ubiquitin ligase in inducing NKG2D ligand expression, we resorted to RNA interference-mediated depletion of DCAF1 (Figure 7). Results shown in Figure S4 demonstrate that infection with HIV-1 and indicated mutant viruses had no effect on the levels of DCAF1 protein. We generated a lentivirus vector, based on FG12 [41], expressing short hairpin RNAs (shRNAs) specific for DCAF1 [42]. Knockdown of DCAF1 expression completely abated the ability of WT DHIV to up-regulate NKG2D ligand expression (Figure 7C) compared with the same infected cells expressing a control (scrambled sequence) shRNA (Figure 7B) or untransduced cells (Figure 7A). Thus, NKG2D ligand expression on HIV-1-infected cells is dependent on the Cul4aDCAF-1 ubiquitin ligase complex.
###end p 36
###begin title 37
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The DCAF1 subunit of Cul4a E3 ubiquitin ligase is involved in the ability of HIV-1 to induce surface expression of NKG2D ligands.
###end title 37
###begin p 38
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 270 275 <span type="species:ncbi:9606">human</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 350 354 <span type="species:ncbi:9925">goat</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
Primary CD4pos T-cell blasts were transduced with shRNA of a DCAF1-specific sequence (C) or an shRNA with a scrambled sequence (B). Untransduced cells were used as a negative control (A). The cells were then infected and stained with anti-CD4 Ab and a fusion protein of human NKG2D and the Fc portion of human IgG1 along with fluorochrome-conjugated goat anti-human IgG1. Transduced cells were detected by GFP expression. The figure is representative data from two separate experiments.
###end p 38
###begin p 39
###xml 25 31 25 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCAF-1</sup>
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bosque1">[37]</xref>
###xml 199 205 199 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCAF-1</sup>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Gasser1">[29]</xref>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Roshal1">[30]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zimmerman2">[35]</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Sarkaria1">[43]</xref>
###xml 528 537 528 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s005">Figure S5</xref>
###xml 620 621 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 651 652 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 673 674 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 678 679 678 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 772 780 772 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g008">Figure 8</xref>
###xml 974 982 974 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g008">Figure 8</xref>
###xml 603 608 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 717 722 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Manipulation of the Cul4aDCAF-1 complex by Vpr results in ATR activation and G2 arrest [37]. It is formally possible that up-regulation of ULBP-1 and -2 is also a consequence of manipulation of Cul4aDCAF-1, but independent of ATR activation. Alternatively, ATR activation may be required for ULBP up-regulation, as was suggested by Gasser et al [29]. To differentiate between these two possibilities, we treated DHIV-infected cells with caffeine, a known inhibitor of ATR and its related kinase, ATM [30],[35],[43]. As shown in Figure S5, caffeine, at a concentration of 4 mM, eliminated the ability of HIV-1 to induce G2 arrest from a ratio of G2+M/G1 = 7.67 to ratio of G2+M/G1 = 0.53. Caffeine (4 mM) treatment of HIV-1-infected cells dampened NKG2D ligand expression (Figure 8; MFI = 277 for caffeine-treated virus-infected cells compared to MFI = 763 for vehicle-treated virus-infected cells). Caffeine had little effect on NKG2D ligand expression on uninfected cells (Figure 8; MFI = 148 for caffeine-treated uninfected cells compared to MFI = 103 for vehicle-treated uninfected cells). Thus, caffeine inhibition of ULBP up-regulation suggests that ATR is a required upstream mediator of NKG2D ligand expression.
###end p 39
###begin title 40
Inhibition of ATR activity relieves Vpr-induced NKG2D-ligand expression.
###end title 40
###begin p 41
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 507 510 507 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 520 523 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 557 560 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 570 573 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 231 236 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
###xml 435 439 <span type="species:ncbi:9925">goat</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 511 516 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 561 566 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary CD4pos T-cells were infected in the presence (C) or absence (B) of the ATR inhibitor, caffeine. As controls CD4pos T-cells were not infected (A) but treated with caffeine or vehicle. Following exposure to 4 mM caffeine and HIV-1 infection, NKG2D ligand expression on the surface of infected cells was measured by staining with a fusion protein of human NKG2D and the Fc portion of human IgG1 along with fluorochrome-conjugated goat anti-human IgG1. The histograms are gated for either 104 viable CD4pos/HIV-1 p24neg cells (blue) or on 104 viable CD4neg HIV-1 p24pos cells (red). This figure is representative of three separate experiments.
###end p 41
###begin p 42
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Sarkaria1">[43]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bryant1">[44]</xref>
###xml 336 344 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g009">Figure 9</xref>
###xml 614 617 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 789 798 781 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s006">Figure S6</xref>
###xml 918 927 910 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g009">Figures 9</xref>
###xml 932 934 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s006">S6</xref>
###xml 89 92 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 236 239 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 868 873 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Since caffeine inhibits both ATR and ATM [43] it is formally possible that the effect of HIV Vpr on ULBP up-regulation is dependent on both ATR and ATM. Thus, to determine any role that ATM may play in the induction of NKG2D ligands by HIV, we evaluated the effect of KU55933, an ATM-specific inhibitor on NKG2D ligand expression [44]. Figure 9 shows that treatment of infected cells with 10 microM KU55933 had little effect on NKG2D ligand expression (MFI = 953) relative to infected cells treated with vehicle alone (MFI = 955). In contrast, KU55933 did affect the level of NKG2D ligands expressed on primary CD4pos T-cells following treatment with aphidicolin, a DNA polymerase alpha inhibitor which induces replication stress (MFI = 432) relative to vehicle-treated cells (MFI = 792) (Figure S6). Unlike KU55933, caffeine prevented NKG2D ligand expression on both HIV-1-infected and aphidicolin treated cells (see Figures 9 and S6). Thus, Vpr induces NKG2D ligand through activation of ATR but not ATM.
###end p 42
###begin title 43
Inhibition of ATM does not affect NKG2D-ligand expression on infected cells.
###end title 43
###begin p 44
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 250 253 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 611 612 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 623 626 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 636 639 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 661 662 653 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 673 676 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 686 689 678 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 276 281 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 347 352 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 505 510 <span type="species:ncbi:9606">human</span>
###xml 551 555 <span type="species:ncbi:9925">goat</span>
###xml 561 566 <span type="species:ncbi:9606">human</span>
###xml 627 632 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 677 682 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary CD4pos T-cells were infected in the presence (B) of the ATM-specific inhibitor KU55933 (10 microM). As a positive control infected cells were treated with 4 mM caffeine (C). Negative controls included vehicle-treated infected cells (A) or CD4pos T-cells infected with HIV-1 lacking Vpr [(DeltaVpr) D]. Following exposure to inhibitors and HIV-1 infection, NKG2D ligand expression on the surface of infected cells was measured by staining with a fusion protein of human NKG2D and the Fc portion of human IgG1 along with fluorochrome-conjugated goat anti-human IgG1. The histograms are gated for either 104 viable CD4pos/HIV-1 p24neg cells (blue) or on 104 viable CD4neg HIV-1 p24pos cells (red). MFI = mean fluorescent intensity. This figure is representative of three separate experiments.
###end p 44
###begin title 45
Up-regulation of ULBP 1 and 2 by Vpr contributes to killing by NK cells
###end title 45
###begin p 46
###xml 637 646 633 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g010">Figure 10</xref>
###xml 820 830 812 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g010">Figures 10</xref>
###xml 835 837 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s007">S7</xref>
###xml 966 976 958 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g010">Figure 10A</xref>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our studies, thus far, demonstrate that HIV-1 induces the expression of ULBP-1 and ULBP-2 through Vpr. However, whether Vpr mediated-induction of ULBP-1 and ULBP-2 on infected cells constitutes a signal that will trigger NK cell lysis remains to be determined. To address this, we compared the ability of primary NK cells to lyse autologous T-cell blasts when infected with either WT or DeltaVpr viruses. As a control, we blocked NKG2D on NK cells prior to exposure to target cells. If NKG2D interaction with its ligands on infected cells had any role in triggering NK cell lysis, then blocking NKG2D would abate the effect. As shown in Figure 10, cells infected with WT virus are sensitive to NK cell lysis, when compared with uninfected cells. Infection with DHIV-DeltaVpr led to a reduced level of NK-mediated lysis (Figures 10 and S7). Although the reduction was not complete, it is noteworthy that deletion of Vpr had a similar effect as the blockade of NKG2D (Figure 10A). These observations, taken together, indicate that up-regulation of NKG2D ligands by Vpr is responsible for a fraction of the observed lytic activity by NK cells. Thus, we conclude that through its known abilities to interact with the Cullin 4a-based E3 ubiquitin ligase and activate ATR, Vpr induces expression of ULBP-1 and -2 and this, in turn, constitutes a signal that triggers NK cell lysis of infected cells.
###end p 46
###begin title 47
Vpr is involved in triggering NK cells to kill the infected cell.
###end title 47
###begin p 48
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 255 257 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 600 602 596 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 664 685 660 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 175 180 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary CD4pos T-cell blasts were infected with HIV-1 that was deficient in expression of Vpr (DeltaVpr) (A&B). As a control, the same cells were infected with wild-type (WT) HIV-1 (A&B). Following infection the infected cells were isolated, labeled with 51Cr and mixed with autologous NK cells at 2.5:1 (open bars) and 5:1 (closed) effector cell to target cell ratios. Each group was done in triplicate. Prior to the lytic assay some of the NK cells were exposed to blocking antibodies to NKG2D (A). At the end of the incubation period culture fluids were harvested and analyzed for the presence of 51Cr. Percent specific lysis was determined as described in the Materials and Methods section. Error bars represent standard deviation of the mean. The figure is representative of two separate experiments. *p<0.05, **p<0.01 by the Student's t-test.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ward1">[24]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 271 280 271 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figures 4</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g005">5</xref>
###xml 101 104 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 194 199 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 380 383 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Our previous studies demonstrated that primary T-cell blasts infected both in vitro and in vivo with HIV expressed, on their cell surface, ligands for NKG2D [24],[25]. Here, we demonstrate that HIV-1 Vpr selectively induces expression of ULBP-1 and ULBP-2 gene products (Figures 4 and 5). ULBP-3, MIC-A and MIC-B were hardly, if at all, up-regulated. We did not observe ULBP-4 on HIV-infected cells using a recently generated anti-ULBP-4 monoclonal antibody (a gift from Dr. John Trowsdale, University of Cambridge, Cambridge, England) in a separate experiment (data not shown).
###end p 50
###begin p 51
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Gasser1">[29]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Gasser1">[29]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Gasser1">[29]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Roshal1">[30]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zimmerman1">[31]</xref>
###xml 702 711 702 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g008">Figures 8</xref>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g009">9</xref>
###xml 394 399 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DNA damage leads to the expression of NKG2D ligands [29]; our observations here indicate that Vpr, through activation of the DNA damage pathway, induces similar effects as those reported by Gasser [29]. This ultimately leads to expression of ULBP-1 and -2 on the cell surface. Despite the potential abilities of both ATM and ATR, following DNA damage, to induce NKG2D ligands [29], only ATR in HIV-1 infected cells appears to trigger the expression of NKG2D ligands. This is consistent with the previously reported specificity of Vpr for ATR and not for ATM [30],[31]. We now show that Vpr enhances NKG2D ligand expression on infected cells and that ATR is required for this novel activity of Vpr (see Figures 8 and 9).
###end p 51
###begin p 52
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ariumi1">[45]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart3">[46]</xref>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Daniel1">[47]</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Daniel2">[48]</xref>
###xml 481 488 481 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart3">[46]</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart3">[46]</xref>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Planelles1">[49]</xref>
###xml 946 950 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Zhou1">[50]</xref>
###xml 951 955 951 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Matsuda1">[51]</xref>
###xml 153 156 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 364 369 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The available literature on whether retroviruses activate DNA damage responses upon integration remains controversial. Several publications propose that HIV (and other retroviruses) do not cause DNA damage signaling when they integrate [45],[46] while others have shown the participation and/or requirement of checkpoint proteins and DNA damage sensors [47],[48]. HIV-1 Vpr activates the DNA damage sensor, ATR, but importantly, Vpr does not do so upon integration, but only after de novo expression in the infected cells, well beyond the integration step [46]. Furthermore, we found no evidence that the presence of Vpr in virions early in infection enhanced the efficiency of viral integration to any degree [46]. Accordingly, Vpr has been shown to exert identical effects on the cell cycle when expressed via systems devoid of viral integration (such as adenoviral vectors, plasmid transfection, and tetracycline-inducible Vpr cell lines [49],[50],[51]).
###end p 52
###begin p 53
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Majumder1">[52]</xref>
###xml 359 362 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 493 502 493 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g001">Figures 1</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s002">S2</xref>
###xml 234 237 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 350 355 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 447 452 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Recent studies from other investigators indicate that soluble Vpr has an impact on NK cell activity [52]. Although we did not directly assess the role of soluble Vpr, our observations produced no evidence that soluble Vpr released by HIV-infected cells would induce NKG2D ligands on uninfected cells. We base this notion on the fact that uninfected (HIV-1 p24neg) cells within infected cultures do not express NKG2D ligands on their surface. Only HIV-1 p24pos cells express NKG2D ligands (see Figures 1 and S2). Hence, we propose that Vpr must be expressed within the infected cells in order to induce NKG2D ligand expression.
###end p 53
###begin p 54
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Cerboni1">[26]</xref>
###xml 557 567 553 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s008">Figure S8B</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 187 192 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 accessory gene products other than Vpr appear to have no effect on the expression of NKG2D ligands. Our observations here are in contrast to those of Cerboni et al. who showed that HIV-1 Nef down-regulates ULBPs from the cell surface of Jurkat T-cells [26]. The contradictory observations made in our studies may suggest that there are differences in the ability of Nef to modulate NKG2D ligands between activated primary T-cells and transformed T-cell lines. The DeltaNef virus we used in our study does not express Nef even though it expresses Vpr (Figure S8B).
###end p 54
###begin p 55
###xml 9 15 9 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCAF-1</sup>
###xml 102 103 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart1">[38]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-DeHart2">[39]</xref>
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Cul4aDCAF-1 ubiquitin ligase contributes to the ability of Vpr to arrest HIV-1-infected cells in G2 phase of the cell cycle [38],[39]; in our current studies we showed that this ligase is important in Vpr-induced NKG2D ligand expression as well. E3 ubiquitin ligases transfer ubiquitin molecules to specific substrates. Poly-ubiquitination can mark substrates for degradation by the proteasome. We attempted to test the role of proteasomal degradation in induction of NKG2D ligands. Unfortunately, proteasome inhibitors were highly toxic to primary T-cells and, therefore, the possible role of proteasomal activity in degrading NKG2D ligands is unknown at this time (data not shown).
###end p 55
###begin p 56
###xml 591 595 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 696 700 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 872 876 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 499 502 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 572 575 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 749 752 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Our expectation was that induction of cell-surface expression of ULBP-1 and ULBP-2, would trigger NK cells to kill infected cells. This indeed is what we found, since NK cells have a decreased ability to lyse virus-infected cells lacking Vpr. Moreover, the reduction in killing activity of the DeltaVpr virus was strikingly similar to that obtained against WT virus-infected cells in which we masked the NKG2D receptor. We have reported, in previous published studies, that variations exist between HIV-infected donors in the capacity of their NK cells to kill autologous HIV-infected cells [25]. We observed killing from as little as 4% and as high as 20% in 8 donors using an E:T ratio of 10:1 [25]. Importantly, The level to which NK cells lysed HIV-infected targets directly correlated with the extent to which ULBP2 was expressed on the surface of the infected cells [25]. Those observations provide indirect support to our model that Vpr, through enhancing ULBP expression, may prime cells for lysis by NK.
###end p 56
###begin p 57
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Mavilio1">[53]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Mavilio2">[54]</xref>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Mavilio1">[53]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 20 23 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 101 108 <span type="species:ncbi:9606">patient</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 433 436 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
NK cell function in HIV-infected individuals is similar to that of uninfected individuals unless the patient is highly viremic [53]. These viremic patients typically possess a dysfunctional NK cell subpopulation lacking CD56 but retaining CD16 [54]. Despite the presence of dysfunctional NK cells in viremic individuals, there are subpopulations of functional NK cells in these patients [53] with residual ability to lyse autologous HIV-infected cells [25]. It has been shown that this residual activity required recognition of NKG2D ligands on the infected cell surface [25].
###end p 57
###begin p 58
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Goh1">[32]</xref>
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 587 590 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Based on our studies, the expected consequence of Vpr's induction of ULBP-1 and -2 would be that HIV-1-infected cells would become sensitive to killing by NK cells. This scenario would clearly be detrimental to virus replication. A logical explanation for this paradox is that up-regulation of ULBPs by Vpr is a downstream consequence of its biological activity (e.g., Vpr induces LTR transactivation in the G2 phase of the cell cycle [32]). Therefore, we hypothesize that other unknown cellular factors may compensate for the activity of Vpr to collectively modulate the sensitivity of HIV-infected cells to lysis by NK cells.
###end p 58
###begin p 59
###xml 155 163 155 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g004">Figure 4</xref>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Cohen1">[55]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Cohen1">[55]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bonaparte1">[56]</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bonaparte1">[56]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bonaparte1">[56]</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Cohen1">[55]</xref>
###xml 1055 1059 1055 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bonaparte1">[56]</xref>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 556 559 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 665 668 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
It is difficult to reconcile how HIV-1 could persist if it increases the likelihood of being destroyed by NK cells through induction of ULBP-1 and ULBP-2 (Figure 4) by Vpr on the cell surface and down modulating ligands (i.e., HLA-A and -B) to NK cell inhibitory receptors by Nef [55]. Part of the answer may lie in the fact that Nef does not down modulate HLA-C and HLA-E [55],[56]. We have published previously [56] that NK cells lacking HLA-C and -E inhibitory receptors kill infected cells by 5-20-fold over unsorted NK cells. Blocking HLA-C and -E on HIV-infected cells from interacting with inhibitory receptors on NK cells enhances NK cells' ability to kill HIV-infected cells [56]. Overall these findings indicate that HLA-C and -E on the infected cells prevent NK cells from killing the infected cells because inhibitory receptors are engaged on NK cells. However, our previous study also indicated that a sufficient number of NK cells lack HLA-C and HLA-E inhibitory receptors and thus would not be inhibited by these MHC class I molecules [55],[56].
###end p 59
###begin p 60
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bryceson1">[57]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Bryceson1">[57]</xref>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ward1">[24]</xref>
###xml 796 800 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ward1">[24]</xref>
###xml 801 805 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Fogli1">[25]</xref>
###xml 147 152 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 706 711 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 741 746 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 981 986 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The presence of ULBP-1, ULBP-2 on the infected cell surface would allow the subpopulation of NK cells not regulated by HLA-C and HLA-E to kill the HIV-1-infected cells. However, NK cells are also regulated at the level of coactivating receptors [57]. Degranulation by NK cells following the triggering of NKG2D requires simultaneous engagement of co-activating receptors such as 2B4 or NTB-A by their ligands on target cells [57]. Therefore, the relatively low lytic activity induced by Vpr through ULBP-1 and -2 induction could be explained on the basis of lack of concomitant induction of coactivating ligands. Recently we demonstrated that co-activating ligands are important for NK cell destruction of HIV-1-infected cells [24] and that HIV-1 down modulates the coactivating receptor ligands [24],[25]. This would then make the infected cell less vulnerable to destruction since activated NK cells will have a reduced ability to degranulate. We are currently investigating how HIV-1 down modulates the ligands for the NK cell coactivating receptors in order to test this hypothesis.
###end p 60
###begin p 61
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 273 278 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our observation that HIV-1 Vpr induces NK cell ligands opens a new set of questions that will need to be addressed in the near future. Specifically, it will be compelling to ascertain whether up-regulation of ULBP-1 and 2 by Vpr can be exploited therapeutically, such that HIV-1 infected cells can be manipulated to become more susceptible to NK lysis; (ii) whether other accessory or, in general, viral proteins can manipulate other aspects of the NK response; and (iii) the signaling steps linking activation of cell cycle checkpoint proteins and the increase in steady-state mRNA levels for NKG2D ligands.
###end p 61
###begin title 62
Materials and Methods
###end title 62
###begin title 63
Antibodies and fusion proteins
###end title 63
###begin p 64
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Simm1">[58]</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 441 445 <span type="species:ncbi:9925">goat</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 614 620 <span type="species:ncbi:9986">rabbit</span>
###xml 626 631 <span type="species:ncbi:10090">mouse</span>
###xml 671 676 <span type="species:ncbi:10090">mouse</span>
###xml 682 687 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 761 766 <span type="species:ncbi:10090">mouse</span>
The mouse anti-human CD4, CD16, CD56, CD112 and MIC-A/MIC-B monoclonal antibodies (mAbs) were obtained from BD Biosciences (). The soluble fusion protein of the NKG2D receptor with the Fc portion of human IgG and mouse anti-human NKG2D, ULBP-1, ULBP-2, and -3 antibodies (Abs) were obtained from R&D Systems (). The anti-MIC-A and MIC-B mAbs that do not cross-react with one another were obtained from Axxora (). The fluorochrome-conjugated goat anti-human IgG1 Fc-specific secondary Ab (with minimal cross-species reaction) was obtained from Jackson ImmunoResearch Laboratories () and the fluorochrome-conjugated rabbit anti-mouse IgG secondary Ab was from Dako (). The mouse anti-HIV-1 p24 mAb, KC57, was obtained from Beckman Coulter (Fullerton, CA) and the mouse monoclonal Ab clone AG3.0 was obtained from the National Institutes of Health AIDS Research and Reference Reagent Program () and was deposited by Dr J. Allan [58].
###end p 64
###begin title 65
Cells and culture reagents
###end title 65
###begin p 66
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 464 467 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 533 536 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 769 775 <span type="species:ncbi:9913">bovine</span>
All primary cells used in this study were isolated from peripheral blood drawn from all healthy donors after informed written consent was obtained in accordance with the Declaration of Helsinki and the policies of the Institutional Review Board at Rush University Medical Center, Chicago, IL. Peripheral blood mononuclear cells (PBMC) were isolated by centrifugation (1000x g, 20 min 20degreesC of peripheral blood over a Ficoll-hypaque gradient (Mediatech, ). CD4pos T-cells were isolated from PBMC by negative selection using a CD4pos T-cell isolation kit (Dynal, ) and stimulated with anti-CD3/anti-CD28 mAb-coated microbeads (Dynal) in RPMI complete medium that consisted of RPMI medium (Mediatech) supplemented with 10% heat inactivated (56degreesC, 30 min) fetal bovine serum (FBS) (Mediatech) and penicillin/streptomycin (Mediatech) before infection with DHIV or transduction with lentivirus vectors. The Jurkat E6-1 cell line was obtained from the American Type Culture Collection () and was maintained in RPMI complete medium. The 293 FT cell line (Invitrogen), used in the generation of virus and vectors, was maintained according to the manufacturer's specifications. Caffeine was obtained from the Sigma Chemical Company (). KU55933 was obtained from Calbiochem (). Aphidicolin was obtained from the Sigma Chemical Company. KU55933 and aphidicolin stock solutions were prepared by dissolving the drugs in DMSO (Sigma Chemical Company) at 1 mM concentration prior to their addition to medium at a final concentration of 10 microM.
###end p 66
###begin title 67
Virus vectors
###end title 67
###begin p 68
###xml 79 84 79 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4/3</sub>
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 151 154 151 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpu</italic>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vif</italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s008">Figure S8</xref>
###xml 54 57 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 74 77 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The envelope-defective DHIV vector is isogenic to the HIV molecular clone HIV-1NL4/3. To construct DHIV vectors with premature stop-codons in the nef, vpu, vif and vpr open reading frames or containing mutated vpr genes, base changes were made by site-directed mutagenesis (Quikchange II XL, ) of subcloned fragments and cloning the mutagenized fragments back into DHIV. All mutations were sequenced to verify accurate mutagenesis, and Western blotting of lysates from DHIV-infected CD4pos Jurkat E6-1 cells was used to verify correct protein expression (Figure S8). DHIV-DeltaVpu was verified to lack Vpu activity by its inability to down modulate CD4 molecules on primary T-cells (data not shown).
###end p 68
###begin p 69
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Hrecka1">[42]</xref>
###xml 206 231 206 231 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GCATATCCACCGTGAGTGT 3&#8242;</named-content>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Qin1">[59]</xref>
###xml 500 509 500 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s009">Figure S9</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Roshal1">[30]</xref>
###xml 558 563 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The FG12 vector system was graciously provided by Dr. Dong Sung An (University of California, Los Angles, CA). The DCAF1_3590 target sequences have been reported previously [42]. The scrambled sequence was 5' GCATATCCACCGTGAGTGT 3'. All target sequences were obtained as olignucleotides (IDT, ), annealed, and inserted downstream of the H1 RNA polymerase III promotor as described [59]. Western blots of lysates of primary activated T-cells transduced with the DCAF_3590 sequence produce less DCAF1 (Figure S9). pPR-Vip, the lentivirus vector that expressed HIV-1 Vpr and GFP, was generated as described previously [30].
###end p 69
###begin p 70
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Andersen1">[36]</xref>
###xml 185 187 185 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> g</italic>
###xml 433 437 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Andersen1">[36]</xref>
###xml 0 26 <span type="species:ncbi:11276">Vesicular stomatitis virus</span>
###xml 28 31 <span type="species:ncbi:11276">VSV</span>
###xml 316 321 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vesicular stomatitis virus (VSV)-G protein pseudotyped FG12, pPR-VIP and DHIV vectors were produced as previously described [36]. Viral vectors were titered by spin-inoculation at 1200x g for two hr at 20degreesC of dilutions of viral supernatant onto the Jurkat E6-1 cell line and detection of either intracellular HIV-1 p24 antigen (DHIV) or GFP expressing cells (FG12) by flow cytometry and the calculation of titers as described [36].
###end p 70
###begin title 71
Infections/transduction
###end title 71
###begin p 72
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-ODoherty1">[60]</xref>
###xml 300 305 300 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4/3</sub>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Lahm1">[61]</xref>
###xml 694 697 694 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 295 298 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Primary T-cells were activated using anti-CD3/anti-CD28 mAb coupled to magnetic beads for 48 hr for DHIV and pPR-VIP or 24 hr for the FG12 vector. Infection/transduction was done by spin-inoculated as described [60] at an MOI of five for DHIV, ten for the FG12 vector, and five for pPR-VIP. For HIV-1NL4/3 infection; an MOI of 0.01 was used. Following the infection, the cells were cultured in RPMI complete medium with 100 U/mL recombinant IL-2 (AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH, deposited by Dr. Maurice Gately, Hoffmann-La Roche Inc, Nutley, NJ; [61]). For experiments where cells were transduced with the FG12 vector and then infected with DHIV, CD4pos T-cells were activated with anti-CD3/anti-CD28 mAb-coated microbeads, transduced with the FG12 vector, cultured for an additional 48 hr, and then infected with DHIV.
###end p 72
###begin title 73
Flow cytometry
###end title 73
###begin p 74
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ward1">[24]</xref>
###xml 210 219 210 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000613.s001">Figure S1</xref>
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 196 201 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 571 576 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Simultaneous detection of surface antigens and intracellular HIV-1 p24 antigen (Ag) was done as previously described [24]. Infected cells were designated by the absence of CD4 and the presence of HIV-1 p24 Ag (Figure S1). For analysis of cell cycle profiles, cells were stained for the appropriate surface markers, washed with FACS buffer (PBS containing 0.1% NaN3 and 2% FBS) fixed for 20 min on ice with 0.25% paraformaldehyde, and permeabilized for 20 min on ice with 0.1% Triton X-100 in PBS. Following a wash in FACS buffer, intracellular staining was performed for HIV-1 p24 Ag and washed a final time. DNA was stained using 1 microM TO-PRO-3 (Invitrogen) in FACS buffer supplemented with 11.25 Kunitz units/mL RNAse (Sigma) and promptly analyzed on an LSR II flow cytometer (BD).
###end p 74
###begin title 75
Purification of infected cells for cytotoxicity assays and real-time RT-PCR
###end title 75
###begin p 76
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
Forty-eight hrs after infection culture, CD4neg p24pos cells were purified by removing CD4pos p24neg cells with anti-CD4 mAb coated magnetic beads (Dynal). To eliminate dead cells the Dead Cell removal kit from Miltenyi was used (). Purity of infected cells was routinely greater than 95% as determined by flow cytometry.
###end p 76
###begin title 77
Real-time RT-PCR
###end title 77
###begin p 78
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Salih1">[62]</xref>
###xml 160 186 160 186 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GCACCGTCAAGGCTGAGAAC 3&#8242;</named-content>
###xml 199 226 199 226 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGATCTCGCTCCTGGAAGATG 3&#8242;</named-content>
###xml 786 787 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 847 851 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Salih1">[62]</xref>
###xml 1064 1065 1044 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1094 1095 1074 1075 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1380 1381 1360 1361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1390 1391 1370 1371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1405 1406 1385 1386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 1424 1425 1404 1405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
Primer pairs for detection of ULBP-1, ULBP-2, ULBP-3, MIC-A and MIC-B were obtained from previous studies described in [62]. The primer pair used for GAPDH was 5' GCACCGTCAAGGCTGAGAAC 3' (sense) and 5' GGATCTCGCTCCTGGAAGATG 3' (antisense). Total RNA was isolated using the RNAqueous Kit (Ambion, ) and treated with DNAse (TURBO DNA-Free, Ambion). Reverse-transcription and real-time RT-PCR reactions were carried out using the Superscript III Platinum Two-Step qRT-PCR kit using Sybr Green chemistry (Invitrogen) according to the manufacturer's protocol. The cDNA was amplified in triplicate with the ABI 7500 Real-Time PCR System (Applied Biosystems, ) with indicated primer pairs for 40 cycles at 95degreesC for 15 sec and 60degreesC for one min. Analysis was done by using the DeltaCT method for relative quantification as previously described [62] except that GAPDH was used as a reference. Similar amplification efficiencies for NKG2D ligand and GAPDH were demonstrated by analyzing serial cDNA dilutions with values of the slope of log cDNA amount vs. DeltaCT of <0.1. Threshold cycles (CT) for GAPDH (reference) and NKG2D ligands (sample) were determined in triplicate. We defined the values obtained for uninfected cells as standard values and determined the relative increase (rI) in copy numbers in relation to these standard values according to the formula: rI = 2-[(CT Sample-CT Reference)-(CT Standard Sample-CT Standard Reference)].
###end p 78
###begin title 79
Cytotoxicity assay
###end title 79
###begin p 80
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000613-Ward1">[24]</xref>
###xml 20 23 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The cytotoxicity of HIV infected cells by autologous NK was measured using the 51Cr release assay. The cytotoxicity assay was done according to the methods previously described in [24].
###end p 80
###begin title 81
Supporting Information
###end title 81
###begin p 82
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 421 422 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 445 448 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 461 464 461 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 505 508 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 214 219 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 449 454 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 509 514 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Gating strategy used for detection of NKG2D ligands on infected cells. Infected primary T-cell blasts and uninfected CD4pos T-cells were surface stained with anti-CD4 Ab. All cells were stained intracellularly for HIV-1 p24 antigen (Ag). Cells were then incubated in the presence of Aquadead stain kit (Invitrogen) to distinguish viable and non-viable cells. Throughout the study NKG2D ligands were evaluated on either 104 viable uninfected (CD4pos HIV-1 p24 Agneg cells) or 104 viable infected cells (CD4neg HIV-1 p24 Agpos). FSC = forward scatter, SSC = side scatter. Gates in red indicate selection process for infected and uninfected cells.
###end p 82
###begin p 83
(2.48 MB TIF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 129 132 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 438 439 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 267 271 <span type="species:ncbi:9925">goat</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 332 337 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NKG2D ligands are not expressed on CD4pos T-cells infected with DeltaVpr HIV-1. Infected primary T-cell blasts and uninfected CD4pos T-cells were surface stained with a fusion protein of human NKG2D and the Fc portion of human IgG1 along with fluorochrome-conjugated goat anti-human IgG1. All cells were stained intracellularly for HIV-1 p24 antigen (Ag). Two-dimensional plots were derived following acquisition on a flow cytometer of 104 viable cells. Markers in dot plots were positioned based on the staining controls. The figure is representative data from three separate experiments.
###end p 85
###begin p 86
(0.98 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 146 149 146 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 77 80 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Effect of point mutations in postions 65 and 80 of Vpr on the cell cylcle of HIV-infected cells. Infected primary T-cell blasts and uninfected CD4pos T-cells were stained with TO-PRO-3 in order to obtain the (G2+M)/G1 ratio.
###end p 88
###begin p 89
(0.67 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 139 142 <span type="species:ncbi:11276">VSV</span>
###xml 157 162 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 191 194 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Expression of DCAF1 is not affected by HIV-1 Vpr. The HeLa cell line was either treated with 10 microM aphidocolin (Aph), or infected with VSV-G pseudotyped HIV-1 with wild-type Vpr (Vpr) or HIV with Q65R and R80A mutations in Vpr (Vpr QR). Following treatment/infection cells lysates were made and western blotted. Western blots were probed with DCAF1 specific antibody.
###end p 91
###begin p 92
(0.56 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 195 200 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 293 298 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inhibition of ATR activity relieves Vpr-induced G2 arrest. Primary CD4pos T-cell blasts were exposed to 4 mM of the ATR inhibitor, caffeine (B and D) or vehicle (A or C) and either infected with HIV-1 (C and D) or left uninfected (A and B). Forty-eight hrs. following exposure to caffeine and HIV-1 infection the cell cycle profile of the uninfected and infected cells were detected by TO-PRO-3 staining.
###end p 94
###begin p 95
(1.50 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 122 125 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 691 692 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 703 706 695 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
###xml 548 552 <span type="species:ncbi:9925">goat</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
Inhibition of ATM activity reduces NKG2D ligand expression on primary CD4pos T-cells treated with aphidocolin. Primary CD4pos T-cells were treated with 10 microM aphidicolin in the presence of 10 microM KU55933 (ATM-specific inhibitor) or 4 mM caffeine. As a negative control aphidicolin-treated cells were exposed to vehicles used to dissolve the inhibitor in solution. Following 48 h exposure to KU55933, caffeine or vehicle the cells were stained with a fusion protein of human NKG2D and the Fc portion of human IgG1 and fluorochrome conjugated-goat anti-human IgG Fc specific antibody (blue line) or secondary antibody alone [staining control (red line)]. The histograms are gated for 104 viable CD4pos cells. This is a representative of two experiments.
###end p 97
###begin p 98
(0.71 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 324 326 320 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 639 641 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">51</sup>
###xml 703 724 699 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 887 896 883 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000613-g010">Figure 10</xref>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 128 133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 250 255 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Ability of NK cells to lyse autologous T-cells infected with HIV-1 lacking Vpr. Primary CD4pos T-cell blasts were infected with HIV-1 that were deficient in expression of Vpr (DeltaVpr). As a control, the same cells were infected with wild-type (WT) HIV-1. Following infection the infected cells were isolated, labeled with 51Cr and mixed with autologous NK cells at 2.5:1 (A and C) and 5:1 (B and D) effector cell to target cell ratios. Prior to the lytic assay some of the NK cells were exposed to blocking antibodies to NKG2D (C and D). At the end of the incubation period culture fluids were harvested and analyzed for the presence of 51Cr. Percent specific lysis was determined as described in the Materials and Methods section. Each point designates a sample from each group. Bars represent the mean percent specific lysis. This supplemental figure is a dot plot representation of Figure 10.
###end p 100
###begin p 101
(1.02 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 547 550 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pos</sup>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 55 60 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Expression of viral proteins by various HIV-1 mutants. HIV-1-infected CD4pos cells were lysed in cell lysis buffer (1% NP-40, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 0.25% Na-deoxycholate, 1 mM EDTA. 1 mM PMSF, 1 mM Na3VO4, 0.1% SDS, and protease inhibitors), run on 15% SDS-PAGE gels, transferred to PVDF, and probed for the indicated proteins with specific antibodies. (A) Lysates from CD4pos cells infected with DHIVDeltaVpr, DHIVDeltaVif, DHIVDeltaVpr,DeltaVif or DHIV containing Vpr with point mutations in specific residues. (B) Lyates from CD4pos T-cells infected with DHIVDeltaNef.
###end p 103
###begin p 104
(3.19 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 388 389 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Ability of shRNA expressing either scrambled or DCAF1 specific sequence to down modulate DCAF1 in transduced cells. Primary T-cell blasts were transduced with the shRNA with specific sequences, sorted by FACS to greater than 95% purity based on GFP expression, lysed in cell lysis buffer (1% NP-40, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 0.25% Na-deoxycholate, 1 mM EDTA. 1 mM PMSF, 1 mM Na3VO4, 0.1% SDS, and protease inhibitors), run on 15% SDS-PAGE gels, transferred to PVDF, and probed for the either DCAF1 or beta-actin proteins with specific antibodies.
###end p 106
###begin p 107
(1.57 MB TIF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
The authors wish to thank Professor Alessandro Moretta (University of Genova, Genova, IT) for providing monoclonal antibodies used in the cytotoxicity assay and Dr. Dong Sung An (University of California, Los Angles, CA, USA) for providing the FG12 vector system. We would like to thank Dr. Linda Baum (Rush University Medical Center, Chicago, IL, USA) for her review and editing of the manuscript. We also thank Kelly Hudspeth and Bharatwaj Sowrirajan (Rush University Medical Center, Chicago, IL, USA) for their excellent technical assistance, and Dr. Alexander Steinle (University of Tubingen, DE) for helpful advice with the real-time RT-PCR.
###end p 109
###begin title 110
References
###end title 110
###begin article-title 111
###xml 83 90 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
###end article-title 111
###begin article-title 112
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 61 66 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.
###end article-title 112
###begin article-title 113
Locally and systemically derived natural killer cells participate in defense against intranasally inoculated influenza virus.
###end article-title 113
###begin article-title 114
###xml 69 96 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections.
###end article-title 114
###begin article-title 115
Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).
###end article-title 115
###begin article-title 116
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.
###end article-title 116
###begin article-title 117
Interleukin-2 and natural killer activity in acute type B hepatitis.
###end article-title 117
###begin article-title 118
Severe herpesvirus infections in an adolescent without natural killer cells.
###end article-title 118
###begin article-title 119
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood.
###end article-title 119
###begin article-title 120
Fatal varicella associated with selective natural killer cell deficiency.
###end article-title 120
###begin article-title 121
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 112 130 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection.
###end article-title 121
###begin article-title 122
###xml 15 33 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Chronic active Epstein-Barr virus infection associated with low expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on natural killer cells.
###end article-title 122
###begin article-title 123
###xml 24 29 <span type="species:ncbi:9606">human</span>
Natural killer cells in human health and disease.
###end article-title 123
###begin article-title 124
###xml 27 32 <span type="species:ncbi:9606">human</span>
Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
###end article-title 124
###begin article-title 125
###xml 28 33 <span type="species:ncbi:9606">human</span>
Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program.
###end article-title 125
###begin article-title 126
Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis.
###end article-title 126
###begin article-title 127
Cytotoxic granules from killer cells: specificity of granules and insertion of channels of defined size into target membranes.
###end article-title 127
###begin article-title 128
Fas-mediated cytotoxicity by freshly isolated natural killer cells.
###end article-title 128
###begin article-title 129
###xml 15 20 <span type="species:ncbi:9606">human</span>
The biology of human natural killer-cell subsets.
###end article-title 129
###begin article-title 130
Up on the tightrope: natural killer cell activation and inhibition.
###end article-title 130
###begin article-title 131
###xml 49 54 <span type="species:ncbi:9606">human</span>
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
###end article-title 131
###begin article-title 132
###xml 110 115 <span type="species:ncbi:9606">human</span>
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells.
###end article-title 132
###begin article-title 133
An activating immunoreceptor complex formed by NKG2D and DAP10.
###end article-title 133
###begin article-title 134
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.
###end article-title 134
###begin article-title 135
###xml 106 109 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.
###end article-title 135
###begin article-title 136
###xml 0 30 <span type="species:ncbi:11676">Human immunodeficiency virus 1</span>
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity.
###end article-title 136
###begin article-title 137
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
###end article-title 137
###begin article-title 138
###xml 52 55 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
###end article-title 138
###begin article-title 139
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.
###end article-title 139
###begin article-title 140
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R.
###end article-title 140
###begin article-title 141
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Immunodeficiency Virus Type 1 Vpr-Mediated G2 Arrest Requires Rad17 and Hus1 and Induces Nuclear BRCA1 and {gamma}-H2AX Focus Formation.
###end article-title 141
###begin article-title 142
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.
###end article-title 142
###begin article-title 143
###xml 79 115 <span type="species:ncbi:11726">simian immunodeficiency virus SIVagm</span>
###xml 120 155 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.
###end article-title 143
###begin article-title 144
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
###end article-title 144
###begin article-title 145
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 84 91 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
###end article-title 145
###begin article-title 146
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT.
###end article-title 146
###begin article-title 147
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells.
###end article-title 147
###begin article-title 148
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 vpr links proteasomal degradation and checkpoint activation.
###end article-title 148
###begin article-title 149
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.
###end article-title 149
###begin article-title 150
###xml 0 4 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
HIV1 Vpr Arrests the Cell Cycle by Recruiting DCAF1/VprBP, a Receptor of the Cul4-DDB1 Ubiquitin Ligase.
###end article-title 150
###begin article-title 151
###xml 86 91 <span type="species:ncbi:9606">human</span>
Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.
###end article-title 151
###begin article-title 152
Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.
###end article-title 152
###begin article-title 153
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
###end article-title 153
###begin article-title 154
Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
###end article-title 154
###begin article-title 155
###xml 70 105 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration.
###end article-title 155
###begin article-title 156
The ataxia telangiectasia-mutated and rad3-related protein is dispensable for retroviral integration.
###end article-title 156
###begin article-title 157
Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response.
###end article-title 157
###begin article-title 158
Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses.
###end article-title 158
###begin article-title 159
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.
###end article-title 159
###begin article-title 160
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel inducible expression system to study transdominant mutants of HIV-1 Vpr.
###end article-title 160
###begin article-title 161
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 76 82 <span type="species:ncbi:9913">bovine</span>
Cell cycle arrest induction by an adenoviral vector expressing HIV-1 Vpr in bovine and feline cells.
###end article-title 161
###begin article-title 162
###xml 28 63 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.
###end article-title 162
###begin article-title 163
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.
###end article-title 163
###begin article-title 164
###xml 104 107 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
###end article-title 164
###begin article-title 165
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 100 103 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.
###end article-title 165
###begin article-title 166
###xml 11 39 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.
###end article-title 166
###begin article-title 167
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.
###end article-title 167
###begin article-title 168
###xml 38 73 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.
###end article-title 168
###begin article-title 169
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.
###end article-title 169
###begin article-title 170
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.
###end article-title 170
###begin article-title 171
###xml 32 37 <span type="species:ncbi:9606">human</span>
Characterization of recombinant human interleukin-2 with micromethods.
###end article-title 171
###begin article-title 172
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.
###end article-title 172
###begin p 173
The authors have declared that no competing interests exist.
###end p 173
###begin p 174
This work was supported by grants from NIH/NIAID (): AI52809 and AI56923 for EB and AI49057 for VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 174

